An Active-Controlled Extension Study to NCT01155466 [P04938] and NCT01227265 [P07037] (P06153)
Clinical trial NCT01215227 · TERMINATED
Trial details
- NCT number
- NCT01215227
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-18
- Primary completion
- 2013-07-16
- Enrollment
- 839
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.